Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00549289 · ClinicalTrials.gov registry record · Phase 3
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)
A Phase 3 study, sponsored by Sirion Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00549289 is a Phase 3 study that has completed, run by Sirion Therapeutics.
The verdict
NCT00549289, a Phase 3 study, has completed, sponsored by Sirion Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The purpose of this phase III, open-label study is to determine the safety and tolerability of cyclosporine in the treatment of dry eye syndrome.
Interventions
- DRUG cyclosporine A
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00549289
The ClinicalTrials.gov registry entry for NCT00549289 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Sirion Therapeutics, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cyclosporine A is the first listed.
NCT00549289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00549289 about?
NCT00549289 is a clinical study titled "Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)". The purpose of this phase III, open-label study is to determine the safety and tolerability of cyclosporine in the treatment of dry eye syndrome.
What is the current status of trial NCT00549289?
This trial is currently completed. It is a Phase 3 study.
What interventions are being tested in trial NCT00549289?
The interventions under investigation include: cyclosporine A (DRUG).
Who is sponsoring clinical trial NCT00549289?
This trial is sponsored by Sirion Therapeutics, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.